Dr Wajiha Javed is a public health physician and epidemiologist with 15+ years of experience in strengthening health  systems, reproductive and maternal health, and communicable and non-communicable disease control. Currently  Associate Director of Public Health Research at Getz Pharma, with prior leadership roles at Pathfinder International,  Jhpiego, and Greenstar Social Marketing. Served as Principal Investigator or Co-Investigator on 20+ large-scale studies  and RCTs, published 20+ peer-reviewed articles, and led Pakistan’s first national COVID-19 seroprevalence study.  Skilled in grant acquisition, policy advocacy, and mentoring health professionals, with a strong record of securing donor  funding and translating research into national health strategies. 

Research Papers

•Javed W. COVID-19 seroprevalence in industrial workers in Pakistan. BMC Infectious Diseases. 2022. 

• Javed W. Urban seroprevalence and implications for COVID-19 fatality estimates. Archives of Epidemiology. 2022. 

• Javed W. Quality of labor and birth care in Sindh, Pakistan. PLOS One. 2019. 

• Javed W. Hypertension care via private facilities in Pakistan: a cluster RCT. BMC Cardiovascular Disorders. 2013. 

• Javed W. Community-Based Savings Groups utilization for midwives in Chitral, Pakistan. BMC Pregnancy and Childbirth. 2013.

 • Javed W. Determinants of never-users of contraception and client satisfaction in Sindh. World Academy of Science. 2015